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Background: it is now well established that HCV is of global importance affecting all countries, leading to a 
major global health problem that requires widespread active interventions for its prevention and control. Chronic 
hepatitis C was linked to the development of cirrhosis and hepatocellular carcinoma (HCC) in many areas of the 
world. WHO reported that Egypt has the highest prevalence (22%) in the world . Objectives: Susceptibility to 
infection has been related to immunological disturbances.HCV and autoimmune hepatitis have been associated 
with HLA A1,A6,A8,-DRB*01-*15 alleles. Methods: HLA alleles were detected by sequence specific 
oligoneucleotide probe (SSOP) using INNO-LiPA based on reverse hybridization after amplification of target 
HLA allele sequence by real time polymerase chain reaction(RT-PCR) . The non-organ-specific antibodies 
include antinuclear (ANA), smooth muscle(ASMA),anti-mitochondrial antibody (AMA), Perinuclear  
antineutrophil cytoplasmic(pANCA), liver-kidney microsomal antibodies (LK/MA ) and anticardiolipn 
antibodies (ACA)were all  measured by commercial  indirect immunofluorescence (IF). Clinical significance of 
these autoantibodies were analyzed in comparison to HCV load by real time polymerase chain reaction (RT-
PCR) and genotype by 4 byline probe assay  INNO-LiPA . Conclusion: Current understanding of genetic basis 
(HLA alleles) of chronic HCV genotype4 cases and autoimmune hepatitis cases free from HCV will aid a lot in 
treating both types of hepatitis using successful line of therapy as early as possible to save money and side effects 
of wrong medications.  
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Staphylococcus epidermidis is one of the most frequent causative agents of nosocomial infections, predominantly 
in patients with indwelling medical devices. This microrganism may form biofilms which are microbial 
structures very tolerant to the host immune defenses and to antibiotherapy. Therefore, studies are needed in order 
to develop effective methods for biofilm control. Currently, bacteriophages (phages) are seen as an important 
tool to combat pathogenic organisms. These bacteria-specific viruses are generally very efficient antibacterial 
agents and possess many advantages over antibiotics. The present study concerns the search for virulent phages 
with broad host range for S. epidermidis biofilm therapy.  
Using wastewater treatment plant raw effluents, a novel phage was isolated and characterized. This virus was 
named phiIBB-SEP1 and TEM micrographs suggested that it belonged to the Twortlikevirus genus. Phage 
phiIBB-SEP1 is able to infect 41 S. epidermidis clinical isolates used in this study, and contrarily to other 
polyvalent viruses of the Twortlikevirus genus, phiIBB-SEP1 is highly specific for S. epidermidis strains. The 
genome of this phage was fully sequenced and presents the typical structure of a member of the Twortlikevirus.
However, when compared to other staphylococcal members of this genus, it showed DNA sequence identities no 
greater than 58.2%, suggesting that phiIBB-SEP1 is a new species within this subfamily.  
Efficacy studies results showed that phage phiIBB-SEP1 is able to cause a 6 Log CFU per ml reduction of the 
cell titre in less than 2h for some of the clinical strains in exponential phase; and, in less than 4h for stationary 
phase cells (using a multiplicity of infection of 1). This phage has also the capacity of reducing, by up to 2 Log 
CFU per ml, 24h scraped biofilm cells, and in some strains it was observed 50% cell reduction. Besides CFU 
counting, this cell reduction was confirmed by flow cytometry counting. Additionally, live/death flow cytometry 
staining allowed the observation that this phage kills biofilms bacteria in different metabolic states. 
These are promising results, since phage phiIBB-SEP1 presents a broad host strain range and the ability to 
control S. epidermidis bacteria in different metabolic states. 
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